Device Trial Radar · NCT04961398
Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements
Last checked: Nov 20, 2026Latest source record: Sep 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
9
Actual
Start
Jun 21, 2021
Primary completion
Jun 24, 2021
Study completion Jun 24, 2021
Sponsor
- Lead sponsor
- Heidelberg Engineering GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 14, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Evaluation of effect of various OCT scan speeds and filters on parameter measurements.
Conditions
- Normal Eyes
Interventions
OCT imagingDevice
OCT imaging on Normal Eyes without any filter and with various ND filters as per protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Macular layer thicknessesTime frame: during the intervention
- Bruch's Membrane Opening (BMO)-Minimum Rim Width (MRW)Time frame: during the intervention
- Peripapillary Retinal Nerve Fiber Layer Thickness (RNFLT)Time frame: during the intervention
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Heidelberg Engineering, Inc.
Franklin, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.